Effects of interferon therapy on inhibition of hepatocellular carcinoma development in patients with chronic hepatitis C

被引：1
|
作者：
Shiratori, Y [1 ]
Yoshida, H [1 ]
Omata, I [1 ]
机构：
[1] Univ Tokyo, Dept Gastroenterol, Tokyo, Japan
来源：
JAPANESE JOURNAL OF CLINICAL ONCOLOGY | 2000年 / 30卷 / 05期
关键词：
D O I：
10.1093/jjco/hyd056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：213 / 214
页数：2
相关论文
共 50 条
  • [1] Interferon therapy prevents the development of hepatocellular carcinoma in chronic hepatitis C patients?
    Okanoue, T
    Itoh, Y
    Minami, M
    Sakamoto, S
    Katagishi, T
    Nishioji, K
    Miyoshi, M
    Sawa, Y
    Nakagawa, Y
    Tada, H
    Kashima, K
    HEPATOLOGY, 1996, 24 (04) : 1082 - 1082
  • [2] Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C
    Imai, Y
    Kawata, S
    Tamura, S
    Yabuuchi, I
    Noda, S
    Inada, M
    Maeda, Y
    Shirai, Y
    Fukuzaki, T
    Kaji, I
    Ishikawa, H
    Matsuda, Y
    Nishikawa, M
    Seki, K
    Matsuzawa, Y
    ANNALS OF INTERNAL MEDICINE, 1998, 129 (02) : 94 - 99
  • [3] Hepatocellular carcinoma development in sustained viral responders to interferon therapy in patients with chronic hepatitis C
    Enokimura, N
    Shiraki, K
    Kawakita, T
    Saitou, Y
    Inoue, H
    Okano, H
    Yamamoto, N
    Deguchi, M
    Sakai, T
    Ohmori, S
    Fujikawa, K
    Murata, K
    Niki, Y
    Nakano, T
    ANTICANCER RESEARCH, 2003, 23 (1B) : 593 - 596
  • [4] Immunodulator Effects of Interferon Therapy on Incidence of Cirrhosis and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
    Kutala, Blaise
    Boyer, Nathalie
    Marchand, Corinne Castelnau
    Guigui, Nathalie Giuily
    Sitruk, Veronique
    Asselah, Tarik
    Marcellin, Patrick
    HEPATOLOGY, 2018, 68 : 407A - 408A
  • [5] Interferon therapy effecacy on hepatocellular carcinoma and chronic hepatitis C patients.
    Abul Futuh, AR
    Solayman, AEM
    Omar, MM
    Bilharse, T
    El Hendawy, SM
    El Hadad, S
    HEPATOLOGY, 2002, 36 (04) : 691A - 691A
  • [6] Incidence of hepatocellular carcinoma after interferon therapy in patients with chronic hepatitis C
    Onodera, H
    Ukai, K
    Suzuki, M
    Minami, Y
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 181 (02): : 275 - 283
  • [7] Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis type C after interferon therapy
    Ishibashi, K
    Kashiwagi, T
    Suzuki, T
    Isoo, Y
    Nagasawa, M
    Toyama, T
    Ozaki, S
    Naito, M
    Azuma, M
    GASTROENTEROLOGY, 1997, 112 (04) : A1290 - A1290
  • [8] Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C
    Yoshida, H
    Tateishi, R
    Arakawa, Y
    Sata, M
    Fujiyama, S
    Nishiguchi, S
    Ishibashi, H
    Yamada, G
    Yokosuka, O
    Shiratori, Y
    Omata, M
    GUT, 2004, 53 (03) : 425 - 430
  • [9] DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C PATIENTS WHO ACHIEVE SUSTAINED VIROLOGICAL RESPONSE TO INTERFERON THERAPY
    Yamashita, N.
    Yamasaki, A.
    Oho, A.
    Kajiwara, E.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S209 - S210
  • [10] Development of hepatocellular carcinoma in patients with chronic hepatitis C treated with interferon-alpha
    Mizokami, M
    Hirashima, N
    Sakakibara, K
    Orito, E
    Nakano, T
    Yamauchi, M
    Ueda, R
    Kage, M
    Kojiro, M
    Lau, JYN
    HEPATOLOGY, 1996, 24 (04) : 1080 - 1080
12345